Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PEOPLE - Changes MIV Therapeutics:

This article was originally published in Clinica

Executive Summary

Following the acquisition of Biosync Scientific, an Indian stent developer (see Clinica No 1246, p 14), MIV Therapeutics, a Vancouver, British Columbia-based developer of biocompatible coatings for implants including cardiovascular stents has appointed the Biosync Scientific management team. Senior executives include: Rajesh Vaishnav (founder and CEO); Anil Misra (president, global marketing & sales); Amitabha Ray (vice-president, global marketing & sales); Abhay Gore (national sales manager); Rohit Chand (manager, clinical trials & regulatory affairs); Kamlesh Tailor (manager, brand promotion); and Shakil Shaikh (distribution manager).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048210

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel